Early Integration of Palliative Care Services in Pediatric Stem Cell Transplant Patients

Laurel Kent1, Molly Williams2, Lisa Pinner3

  • 1Laurel Kent, MSN, FNP, RN , is nurse practitioner, Center for Advanced Practice, Pediatric Stem Cell Transplant, Stanford Medicine Children's Health, Palo Alto, CA.

Insights

A new palliative care trigger tool effectively identified pediatric stem cell transplant patients needing early palliative care services. This tool improved the integration of crucial support, enhancing symptom management and quality of life during treatment.

Area of Science:

  • Pediatric Hematology
  • Palliative Care Medicine
  • Evidence-Based Practice

Background:

  • Hematopoietic stem cell transplant (HSCT) patients face significant risks of morbidity and mortality.
  • Early integration of palliative care is crucial for managing symptoms and improving quality of life in these patients.

Purpose of the Study:

  • To evaluate the impact of a palliative care trigger tool on the number of palliative care consults and early service integration in pediatric HSCT patients.
  • To determine the tool's effectiveness in identifying high-risk patients for timely palliative care.

Main Methods:

  • Development and implementation of a palliative care trigger tool on a pediatric HSCT unit over 6 months.
  • Retrospective chart review to assess patient qualification for and receipt of palliative care services before and after tool implementation.

Main Results:

  • Before tool implementation, 35% of patients met criteria for early palliative care, but only 29% received it.
  • After implementation, 52% of transplant patients qualified for palliative care, and 80% received it, demonstrating improved service delivery.

Conclusions:

  • The palliative care trigger tool is effective in identifying pediatric HSCT patients eligible for early palliative care integration.
  • The tool successfully increased the provision of palliative care services to identified high-risk patients, supporting symptom management, quality of life, and decision-making.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
910
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.9K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
349
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
249